Symptoms of Post-Vaccination Syndrome Revealed In New Study From Yale University


In a new exploration into the lesser-known aftermath of COVID-19 vaccinations, a recent study has revealed a series of neurological symptoms that linger long after the jab. Led by Dr. Harlan Krumholz from Yale School of Medicine, this inquiry delves into a condition now referred to as Post-Vaccination Syndrome (PVS).

The study, titled "Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization," was published as a preprint. Although it awaits further peer review, it's a monumental step in understanding the rare but chronic and debilitating effects of PVS.

"It raises awareness about what these individuals are experiencing and points attention to the need for more studies to understand what is underlying this condition and how to relieve suffering," Dr. Krumholz said. "These people are not anti-vaxxers -- they were all vaccinated -- but because of politics, many have had the experience of being dismissed and ignored."

Out of 241 individuals who reported PVS, the most prevalent symptoms included exercise intolerance, extreme fatigue, numbness, brain fog, and neuropathy.

Interestingly, the definition of PVS itself is still evolving. It's generally considered as symptoms starting within a week of vaccination and persisting for at least two months. This condition is rare, and studies specifically focusing on it are scarce.

The National Institutes of Health (NIH) funded a study, also featured on medRxiv, which investigated new neuropathic symptoms in 23 individuals after COVID vaccination. Over half of them displayed clinical signs of small-fiber peripheral neuropathy, with some showing improvement with oral corticosteroid treatment. In addition to neuropathy, other post-vaccine conditions like tinnitus and Postural Orthostatic Tachycardia Syndrome (POTS) have been observed.

But it's crucial to note that immune-mediated neurological adverse events after vaccination are rare and often less severe than those following actual COVID-19 infection.

The demographic in the Yale University's study comprised predominantly women, white, and U.S. residents, with a median age of 46. Notably, these participants were excluded if they had long COVID. The onset of PVS symptoms generally occurred within three days of vaccination, with a staggering median number of 22 symptoms reported per participant.

Aside from physical ailments, the psychological impact of PVS is profound, with many participants reporting feelings of unease, fearfulness, anxiety, and even depression. This highlights the multifaceted nature of PVS, affecting not just physical health but mental well-being too.

Despite the study's limitations, including self-reported symptoms and a non-representative participant group, it opens up a crucial dialogue in the medical community. As Dr. Krumholz suggests, the next phase involves correlating these experiences with in-depth immune function studies.

This research is not just a collection of data but a beacon of hope for those silently enduring the aftereffects of COVID-19 vaccinations. It's a call to the scientific community to delve deeper, understand better, and ultimately find solutions for those suffering from these lingering and life-altering symptoms

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

Comments / 410

Published by

MSc (Research) | Named Standford's world's top 1% scientists | Independent scientist | 10x first-author academic papers | 400+ articles on coronavirus


More from Shin

Comments / 0